Resumen
This review article explores the forefront of research and technology in the detection and isolation of circulating tumor cells (CTCs) for liquid biopsy applications. Traditional biopsies, which necessitate tissue samples, are invasive and often challenging for patients. In contrast, liquid biopsies provide a less invasive alternative, enabling the continuous monitoring of the cancer?s progression and the effectiveness of treatments. Recent advancements have significantly enhanced our understanding of CTCs, underscoring their critical role in cancer research and patient management. This article aims to highlight these technological innovations and their potential to transform cancer diagnosis, prognosis, and personalized therapy, offering new hope for improved patient outcomes in the fight against cancer.